Suggestions
Michael Packham
Commercial Real Estate Executive
Michael Packham is an experienced commercial real estate executive with a career spanning 26 years across multiple countries, including Canada, USA, LATAM, Caribbean, Russia, and Central Europe. He currently serves as the CEO/Director at Packham International Group Limited, a commercial real estate boutique offering 28 years of international experience in leasing, investment, marketing, branding, and strategy.1
Packham's expertise encompasses various aspects of the real estate industry, including:
- Leasing
- Asset management
- Development marketing
- Property management
- Project management
- Investment
- Branding
- Acquisitions
- Developer/landlord representation
- Tenant representation
- C-level business development
- Transaction management
- Lease administration
- Research
- Portfolio optimization
Throughout his career, Packham has provided advisory services to numerous developers, professional services firms, and Fortune 500 companies, handling transactions valued at over $5 billion. His educational background includes a BA in Law from Carleton University and real estate programs completed at Humber College and Algonquin College of Applied Arts and Technology.
Packham's professional journey includes notable roles such as:
- Partner in Strategic Initiatives at Buygoon Inc.
- Vice President of Asset Management, Commercial Leasing, Property Management & Operations at Pinnacle International Realty Group
- Commercial Director, Americas at RICS
- Director of Commercial Leasing at The Skyline Group of Companies
- Office Leasing Director at PPF Real Estate
- Director at CBRE
- Office Leasing Director at AIG/Lincoln
- Leasing & Marketing Director at GE Capital
- Managing Director of Tenant Representation at Colliers International
- Associate at Colliers International
- Research Analyst at J.J. Barnicke
In addition to his professional activities, Packham is involved in charitable efforts. For instance, he participated in the Terry Fox Run with "Team Packham" to support cancer research.2